Latest S-1 registration statements

Spectaire Holdings Inc. files an amendment to its Form S-1 registration statement related to the potential sale of up to 3,067,438 shares of common stock by Keystone Capital Partners, LLC.

Kyverna Therapeutics is seeking to raise approximately $182.3 million through an initial public offering to further the clinical development of its cell therapies for autoimmune diseases.

Safe & Green Holdings Corp. is registering for resale up to 3,510,302 shares of its common stock by existing stockholders, including shares issuable upon conversion of a debenture and exercise of a warrant.

Expion360 files an amendment to its Form S-1 registration statement to register the resale of up to 1,781,978 shares of common stock by Tumim Stone Capital, LLC, pursuant to an equity line purchase agreement.

180 Life Sciences Corp. is registering for resale up to 13.95 million shares of its common stock potentially issuable upon the exercise of existing warrants held by a selling stockholder.

Aclarion files an amendment to its S-1 registration statement to allow White Lion Capital to resell up to 2,500,000 shares of common stock, while addressing Nasdaq compliance and going concern uncertainties.

Abacus Life, Inc. plans to offer additional 9.875% fixed-rate senior notes due 2028 to refinance debt and for general corporate purposes.

Inspire Veterinary Partners is registering for resale up to 7,869,182 shares of its Class A common stock by selling stockholder Tumim Stone Capital LLC, potentially generating up to $30 million in gross proceeds for the company.

Armlogi Holding Corp. has filed an amendment to its Form S-1 registration statement, signaling progress towards its initial public offering and Nasdaq listing.

GRI Bio launches a public offering of common stock and warrants aiming to raise $8 million for clinical trials and Nasdaq compliance.

Invech Holdings, Inc. files an S-1 registration statement for the resale of up to 2,462,293 shares of its common stock by existing shareholders.

SeqLL Inc. files an amendment to its registration statement for a $20 million unit offering and details its proposed merger with Lyneer Investments LLC.

BIOLASE, Inc., a leading provider of advanced laser systems for the dental industry, is offering up to $7.48 million in units and pre-funded units in a best efforts offering.

Nuwellis, Inc. announces a proposed offering of up to 16,326,530 units to raise up to $8 million for working capital and commercialization.

GRI Bio launches a public offering of common stock and warrants to raise up to $8 million as it faces Nasdaq listing deficiencies and aims to fund clinical trials.

IB Acquisition Corp., a blank check company, files an amendment to its S-1 registration statement for a proposed $100 million initial public offering.

BIO-key International is registering the resale of up to 436,509 shares of its common stock by a selling stockholder, Dillon Hill Investment Company LLC, with the company not receiving any proceeds from the sale.

Bone Biologics Corporation is seeking to raise capital through a public offering of common stock, pre-funded warrants, and common warrants, aiming to fund clinical trials and extend its patent portfolio.

Chromocell Therapeutics aims to raise capital for pain therapeutics development through an initial public offering.

Artificial Intelligence Technology Solutions (AITX) has filed a registration statement for the resale of up to one billion shares of its common stock by GHS Investments, LLC, potentially generating up to $8 million in gross proceeds for the company.

Revelation Biosciences files an amendment to its S-1 registration statement for a proposed public offering of common stock and warrants.

Aceztech Corporation addresses SEC concerns in an amended S-1 filing, proceeding with a direct public offering of 6,000,000 shares at $0.02 per share to raise up to $120,000.

Revelation Biosciences plans a best efforts public offering of common stock, pre-funded warrants, and Class D Common Stock Warrants to raise capital for clinical development and general corporate purposes.

Hempacco Co., Inc. has filed an S-1 registration statement for the resale of up to 6,600,295 shares of common stock by selling stockholders following recent private placement transactions.

Trio Petroleum Corp. has filed a registration statement for the resale of up to 4,088,980 shares of common stock issuable upon conversion of a note and exercise of warrants.

Legato Merger Corp. III, a blank check company, files an amendment to its S-1 registration statement for a $175 million initial public offering targeting infrastructure, engineering, construction, industrial, and renewables sectors.

Longeveron is registering the resale of up to 1,450,172 shares of its Class A Common Stock by selling stockholders, issuable upon the exercise of certain warrants.

SSHT S&T Group Ltd. is proceeding with a direct public offering of 100,000,000 shares of common stock at $0.01 per share to raise capital for working capital and general corporate purposes.

Alto Neuroscience files an amendment to its S-1 registration statement, primarily to update the filing fee table for its proposed IPO.

Calidi Biotherapeutics plans to offer common stock, pre-funded warrants, and common stock purchase warrants in a best efforts offering.